Neoadjuvant FLOT/MAGIC vs. CROSS in Distal Esophageal

I'm at a major academic center and the other day it was suggested that we should start considering neoadjuvant chemo alone for distal esophageal cancers based on this abstract at ASCO. Every single reported metric in the table below was superior for CROSS and yet the conclusion was "the data strongly suggests non-inferiority and equipoise." When us doom and gloomers talk about the declining indications for radiation it's because of things like this. We're perpetually one successful chemo... Read more
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Radiation Oncology Source Type: forums